Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide vs Autologous Serum in Sjögren's Syndrome Dry Eye
NCT03608761Phase 4Completed
- Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Start
- Feb 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rebamipide in dry eye syndrome (DED), Sjögren's syndrome, sponsored by Hospital Nacional Profesor Alejandro Posadas. Started Feb 2017; status: completed.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on NCT03608761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03608761.